CD274 and pancreatic neoplasm: Just recently, the group of Park and colleges demonstrated that in pancreatic cancer, a tumor entity that closely resembles BTC in terms of prognosis and tumor biology, PD-L1 levels at diagnosis exhibit a prognostic value and that the course of PD-L1 concentrations correlates with clinical outcome [17].